Allovir Performance
| ALVRDelisted Stock | USD 9.81 0.26 2.72% |
The firm shows a Beta (market volatility) of 0.49, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Allovir's returns are expected to increase less than the market. However, during the bear market, the loss of holding Allovir is expected to be smaller as well. Allovir right now shows a risk of 0.0%. Please confirm Allovir standard deviation, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if Allovir will be following its price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Allovir has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Allovir is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors. ...more
Allovir |
Allovir Relative Risk vs. Return Landscape
If you would invest 981.00 in Allovir on November 10, 2025 and sell it today you would earn a total of 0.00 from holding Allovir or generate 0.0% return on investment over 90 days. Allovir is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Allovir, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Allovir Target Price Odds to finish over Current Price
The tendency of Allovir Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 9.81 | 90 days | 9.81 | about 60.38 |
Based on a normal probability distribution, the odds of Allovir to move above the current price in 90 days from now is about 60.38 (This Allovir probability density function shows the probability of Allovir Stock to fall within a particular range of prices over 90 days) .
Allovir Price Density |
| Price |
Predictive Modules for Allovir
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Allovir. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Allovir's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Allovir Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Allovir is not an exception. The market had few large corrections towards the Allovir's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Allovir, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Allovir within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.24 | |
β | Beta against Dow Jones | 0.49 | |
σ | Overall volatility | 0.57 | |
Ir | Information ratio | -0.07 |
Allovir Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Allovir for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Allovir can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Allovir is now traded under the symbol KLRS. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Allovir is not yet fully synchronised with the market data | |
| Allovir has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (58.77 M) with profit before overhead, payroll, taxes, and interest of 165 K. | |
| Allovir currently holds about 172.67 M in cash with (67.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.91. | |
| Roughly 49.0% of the company shares are held by company insiders |
Allovir Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Allovir Stock often depends not only on the future outlook of the current and potential Allovir's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Allovir's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5 M | |
| Cash And Short Term Investments | 118.3 M |
Allovir Fundamentals Growth
Allovir Stock prices reflect investors' perceptions of the future prospects and financial health of Allovir, and Allovir fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Allovir Stock performance.
| Return On Equity | -0.8 | |||
| Return On Asset | -0.37 | |||
| Current Valuation | (69.57 M) | |||
| Shares Outstanding | 115.36 M | |||
| Price To Book | 0.43 X | |||
| EBITDA | (65.44 M) | |||
| Cash And Equivalents | 172.67 M | |||
| Cash Per Share | 1.91 X | |||
| Total Debt | 5.24 M | |||
| Debt To Equity | 0.14 % | |||
| Book Value Per Share | 1.05 X | |||
| Cash Flow From Operations | (67.7 M) | |||
| Earnings Per Share | (0.90) X | |||
| Total Asset | 118.55 M | |||
| Retained Earnings | (714.96 M) | |||
| Current Asset | 61.62 M | |||
| Current Liabilities | 53.23 M | |||
About Allovir Performance
Assessing Allovir's fundamental ratios provides investors with valuable insights into Allovir's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Allovir is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell therapies to prevent and treat devastating viral-associated diseases. Allovir, Inc. was founded in 2013 and is based in Waltham, Massachusetts. Allovir operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 107 people.Things to note about Allovir performance evaluation
Checking the ongoing alerts about Allovir for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Allovir help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Allovir is now traded under the symbol KLRS. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Allovir is not yet fully synchronised with the market data | |
| Allovir has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (58.77 M) with profit before overhead, payroll, taxes, and interest of 165 K. | |
| Allovir currently holds about 172.67 M in cash with (67.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.91. | |
| Roughly 49.0% of the company shares are held by company insiders |
- Analyzing Allovir's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Allovir's stock is overvalued or undervalued compared to its peers.
- Examining Allovir's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Allovir's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Allovir's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Allovir's stock. These opinions can provide insight into Allovir's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in Allovir Stock
If you are still planning to invest in Allovir check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Allovir's history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |